Hisamitsu Pharmaceutical Co (TSE:4530) Change In Receivables : 円0 Mil (TTM As of Nov. 2023)

View and export this data going back to 1962. Start your Free Trial

What is Hisamitsu Pharmaceutical Co Change In Receivables?

Hisamitsu Pharmaceutical Co's change in receivables for the quarter that ended in Nov. 2023 was 円0 Mil. It means Hisamitsu Pharmaceutical Co's Accounts Receivable stayed the same from Aug. 2023 to Nov. 2023 .

Hisamitsu Pharmaceutical Co's change in receivables for the fiscal year that ended in Feb. 2024 was 円-2,082 Mil. It means Hisamitsu Pharmaceutical Co's Accounts Receivable increased by 円2,082 Mil from Feb. 2023 to Feb. 2024 .

Hisamitsu Pharmaceutical Co's Accounts Receivable for the quarter that ended in Nov. 2023 was 円42,412 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Hisamitsu Pharmaceutical Co's Days Sales Outstanding for the three months ended in Nov. 2023 was 107.95.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Hisamitsu Pharmaceutical Co's liquidation value for the three months ended in Nov. 2023 was 円103,107 Mil.

Hisamitsu Pharmaceutical Co Change In Receivables Historical Data

The historical data trend for Hisamitsu Pharmaceutical Co's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hisamitsu Pharmaceutical Co Change In Receivables Chart

Hisamitsu Pharmaceutical Co Annual Data

Trend

Feb15

Feb16

Feb17

Feb18

Feb19

Feb20

Feb21

Feb22

Feb23

Feb24

Change In Receivables

Get a 7-Day Free Trial

-9,422.00

8,955.00

2,191.00

780.00

-2,082.00

Hisamitsu Pharmaceutical Co Quarterly Data
	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
Change In Receivables	Get a 7-Day Free Trial															-	-	-	-	-

Hisamitsu Pharmaceutical Co Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Nov. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0 Mil.

Hisamitsu Pharmaceutical Co (TSE:4530) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Hisamitsu Pharmaceutical Co's Days Sales Outstanding for the quarter that ended in Nov. 2023 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	42412	/	35850	*	91
=	107.95

2. In Ben Graham's calculation of liquidation value, Hisamitsu Pharmaceutical Co's accounts receivable are only considered to be worth 75% of book value:

Hisamitsu Pharmaceutical Co's liquidation value for the quarter that ended in Nov. 2023 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	123912	-	63417	+	0.75 * 42412	+	0.5 * 21606
=	103,107

Hisamitsu Pharmaceutical Co Change In Receivables Related Terms

Thank you for viewing the detailed overview of Hisamitsu Pharmaceutical Co's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Hisamitsu Pharmaceutical Co (TSE:4530) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hisamitsu Pharmaceutical Co Inc (TSE:4530) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

HPX:Germany

Address

408 Tashiro Daikan-machi, Tosu, Saga, JPN, 841-0017

Website

http://www.hisamitsu.co.jp

Hisamitsu Pharmaceutical Co Inc is a major pharmaceutical products manufacturer in Japan. The company collaborates with its subsidiaries and associates in operating its business across two segments, The Medical and Related Product segment and the Others segment. The Medical segment represents the company's foremost revenue generating operations. It markets drugs under the Salanpas, Salonsip, Lifecella, Mohrus and Keplat brands, which mainly serve topical medication needs with pain relief creams, gels, sprays, lotions and ointments. The Others segment refers to its miscellaneous businesses such as cable television broadcasting, internet connection, packing materials and insurance. Apart from its primary market in Japan, Hisamitsu has a reach across other regions like North America.

Hisamitsu Pharmaceutical Co (TSE:4530) Headlines

No Headlines